Article
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
9 Jun 2022
Abstract excerpt
BACKGROUND: The dynamic epigenome and proteins specialized in the interpretation of epigenetic marks critically contribute to leukemic pathogenesis but also offer alternative therapeutic avenues. Targeting newly discovered chromatin readers involved in leukemogenesis may thus provide new anticancer strategies. Accumulating evidence suggests that the PRC1 complex member CBX2 is overexpressed in solid tumors and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
